In 2021, the global NGS kits market was valued at $4,553.6 million, and it is expected to reach $26,057.4 million by 2032, growing at a CAGR of 17.27% during the forecast period 2022-2032.

The growth in the global NGS Kits market is expected to be driven by advancements in sequencing technology benefiting the treatment and diagnostics coupled with the presence of regulatory framework pertaining to sequencing and governments investing in large clinical and diagnostic laboratories to enable reliable NGS testing for a variety of chronic and infectious ailments.

Market Lifecycle Stage

The global NGS kits market is in progressing phase. Next-generation sequencing (NGS) has recently seen a rapid surge in popularity and has emerged as a crucial diagnostic tool for many diseases. The NGS kits market is a disruptive technical advancement in the life sciences sector that has cleared the way for the creation of various ground-breaking medicinal techniques intended to solve the main global health concern.

Impact

• The presence of NGS kits providers of NGS kits in regions such as North America and Europe has a major impact on the market.

For instance, Illumina, Inc. is one of the global leaders in providing technologically advanced sequencing and array-based solutions for genomic and genetic analysis to government laboratories, academic and research institutions, hospitals, pharmaceuticals, commercial molecular diagnostic laboratories, biotechnology, and consumer genomics companies. The company also provides sequencing solutions in the field of cancer research.

Impact of COVID-19

The COVID-19 pandemic has resulted in showcasing a positive impact on the overall market, owing to its increased adoption for the diagnosis of respiratory virus i.e. coronavirus. NGS is a useful technology for characterizing and finding viruses in the environment, animals, and people during viral pandemics.

Additionally, NGS can offer helpful information to researchers and medical professionals who are trying to create the best possible treatment alternatives. Steps performed in the COVID-19 testing process include extracting RNA sample from the patients, which is then reverse transcribed to cDNA, and then amplified using PCR.

Before the PCR step, however, a sample library needs to be prepared which is the most time-consuming step of the entire process. Thus, with the help of NGS kits, this protocol can be performed quickly. Therefore, with the emergence of COVID-19, the popularity of NGS kits has increased.

Market Segmentation:

Segmentation 1: by Workflow

• Library Preparation
• Cluster Generation
• Sequencing Reagents/Kits

The global NGS Kits market in the workflow segment is expected to be dominated by the library preparation segment. This is due to an increasing number of library preparation kits and companies manufacturing these kits for their end users.

Segmentation 2: by Sequencing Type

• WES and WGS
• Targeted Sequencing
• Long-Read Sequencing
• Others

The global NGS Kits market is dominated by the WES and WGS segment owing to an increasing number of NGS kits targeting whole exome and whole genome as part of the sequencing step. Whole exome sequencing (WES) is a useful method for researchers. This kind to research might be used to continue figuring out whether new genetic variations are connected to health problems, which could help identify illnesses in the future.

WGS is a technique for figuring out a person’s complete DNA sequence, including non-coding DNA, which has about 3 billion nucleotides. In recent years, the cost of producing genetic data has decreased significantly. The demand for library preparation in WGS is being driven by the continuing demand for WGS in clinical and scientific applications, as well as the growing need to discover new genomic variants connected to health concerns.

Segmentation 3: by Usage

• Clinical
• Research

The global NGS Kits market is dominated by the research segment owing to rising number companies manufacturing research use NGS kits and rising R&D activity focused on NGS kits. There has been extensive use of NGS-detected sequence variants/mutations in research, including prognosis, therapeutic decision-making, and patient follow-up. Its extensive parallel sequencing capacity creates new opportunities for personalized therapy.

Segmentation 4: by Application

• Oncology
• Rare Diseases
• Genetic Disorders
• Reproductive Health
• Others

The global NGS Kits market is dominated by the oncology segment owing to rising number companies manufacturing NGS kits for cancer. Cancer is a diverse illness that develops over time because of an accumulation of DNA abnormalities.

The detection, management, and therapy of cancer would significantly impact by new sequencing technology. A road map of the typical human genome and a landscape of mutations in cancer genomes spanning many cancer types are provided by the hundreds of cancer genomes that have been read by next-generation sequencing (NGS).

Segmentation 5: by End-User

• Academic and Research Institutions
• Pharmaceutical and Biotechnology Companies
• Clinical and Diagnostic Laboratories
• Others

The academic and research institutions segment dominates the global NGS Kits market due to the increasing research and development activities in academic institutes and the focus of researchers on NGS kits.

Segmentation 6: by Region

• North America – U.S., Canada
• Europe – U.K., Germany, France, Italy, Spain, and Rest-of-Europe
• Asia-Pacific – Japan, China, India, South Korea, Australia, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, and Rest of Latin America
• Rest-of-the-World

North America generated the highest revenue of $2,281.5 million in 2021, which is attributed to the R&D advancements in the field of NGS and the presence of dominating players operating in the NGS kits market.

The growth in this region can be attributed to the presence of prominent market players in the U.S. and the growing adoption of next-generation sequencing kits in research, diagnostics, and synthetic biology.

In addition, the rising prevalence of infectious diseases, genetic disorders, and chronic diseases, and the development of novel library preparation kits are some of the factors that is leading to the dominance of North America in the global NGS kits market.

Recent Developments in the Global NGS Kits Market

• In June 2022, PerkinElmer Inc. introduced the library preparation kits i.e. NEXTFLEX Small RNA-Seq Kit v4, NEXTFLEX Rapid XP V2 DNA-Seq Kit and PG-Seq Rapid Kit v2.

• In June 2022, Beckman Coulter, Inc. partnered with Integrated DNA Technologies to distribute Biomek NGenius Next-Generation Sequencing Library Prep System. This system is a multipurpose liquid handler for NGS library preparation. The Biomek NGenius System is equipped with an FFPE DNA library prep kit and Integrated DNA Technologies’ xGen cfDNA, which can help researchers optimize library generation from degraded, low-input samples such as the FFPE samples.

• In March 2022, Illumina, Inc. launched the TruSight Oncology (TSO) Comprehensive (EU), a single test that detects multiple tumor genes and biomarkers to reveal the specific molecular profile of a patient’s cancer. With its global launch in Europe, the IVD kit is manufactured to inform precision medicine decisions for cancer patients across the continent.

• In February 2020, Thermo Fisher Scientific introduced a new NGS-based solution that enables reproductive health researchers to analyze a broad range of key genetic markers. The Ion Torrent CarrierSeq ECS Kit for the Ion GeneStudio S5 System consolidated a multi-platform approach to expanded carrier screening (ECS) into a single solution that expands the company’s reproductive health research portfolio.

Demand – Drivers and Limitations

Following are the demand drivers for global NGS kits market:

• Increasing Incidence of Infectious Diseases and Genetic Disorders
• Exponential Rise in Next-Generation Sequencing (NGS) Demand due to Reducing Cost of Genome Sequencing
• Rising Research Funding in the Genome Sciences

The market is expected to face some limitations too due to the following challenges:

• Dearth of Skilled Professionals and Lack of Infrastructure in Emerging Economies
• Stringent Regulatory Standards Related to NGS

How can this report add value to an organization?

Workflow/Innovation Strategy: The workflow segment helps the reader understand the two NGS steps i.e Library preparation, Cluster Generation and Sequencing. Under these steps, NGS kits are used which further aid in diagnosis. Moreover, the study provides the reader with a detailed understanding of the different applications such as oncology, NIPT, rare disease, and others.

Growth/Marketing Strategy: The NGS kits are being used for both research and clinical application. Companies are providing these kits, which is key for market players to excel in the current NGS kits market.

Competitive Strategy: Key players in the global NGS Kits market analyzed and profiled in the study have involved the NGS kits as product manufacturers Moreover, a detailed competitive benchmarking of the players operating in the global NGS Kits market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration. The leading top segment players include NGS kit manufacturers that offer major products under workflow such as library preparation, cluster generation, and sequencing in the market.

Some of the prominent names established in this market are:

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• BGI Group
• Creative Biogene.
• Danaher.
• F. Hoffmann-La Roche Ltd
• Hologic, Inc.
• Illumina, Inc.
• New England Biolabs
• Oxford Nanopore Technologies plc.
• Pacific Biosciences of California, Inc.
• PerkinElmer Inc.
• Promega Corporation
• QIAGEN N.V.
• seqWell
• Takara Bio Inc.
• Tecan Trading AG
• Thermo Fisher Scientific, Inc.
• Twist Bioscience Corporation

The post NGS Kits Market – A Global and Regional Analysis: Focus on Workflow, Sequencing Type, Usage, Application, End User, and Region – Analysis and Forecast, 2022-2032 first appeared on CRI Report.

Market Segmentation

• Product Type (AI-Integrated Hardware and Software and Services)
• Technology (Machine Learning, Deep Learning, Natural Language Processing, Computer Vision, and Others)
• Application (Medical Imaging and Diagnosis, Data Management, Telemedicine, Remote Monitoring and Lifestyle Management, Robot-Assisted Surgery, Drug Discover and Clinical Trials, Virtual Assistance, and Others)
• End User (Patients, Healthcare Providers, Academic Institutes and Research Centers, Pharmaceutical Companies, Healthcare Insurance, and Others)

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, France, Italy, U.K., Spain and Rest-of-Europe
• Asia-Pacific – China, Japan, India, Australia, South Korea and Rest-of-Asia-Pacific
• Rest-of-the-World – Brazil, Mexico, Argentina and Rest-of-Rest-of-the-World

Growth Drivers

• Growing Need for Patient-Centric Care
• Growing Applications of AI in Healthcare Informatics
• Shortage of Healthcare Workforce
• Increasing Complexities of Clinical Decision Making
• Progress in Healthcare IT

Market Challenges

• Lack of Clearly Defined Regulations
• Data Security and Privacy Concerns
• Barriers to Physician’s Adoption of AI
• Legal Implications of AI Systems

Market Opportunities

• Capitalizing on Unmet Clinical Demand
• Enabling Care At-Home: Remote Monitoring
• Leveraging Rapid Development in Deep Learning
• Unlocking the Combined Potential of AI and Robotics

Key Companies Profiled

Activ Surgical, Inc., Atomwise, Inc., Babylon Health, BenevolentAI, Butterfly Network, Inc., Freenome, General Electric Company, International Business Machines Corporation (IBM), Koninklijke Philips N.V., Nuance Communications, Inc., Nvidia Corporation, Olive, Siemens Healthineers AG, Viz.ai, Inc., and Zebra Medical Vision Ltd.

Key Questions Answered in this Report:

• What are the key regulations governing AI adoption in healthcare across various regions?
• Which start-ups received significant funding in 2020?
• What has been the impact of the COVID-19 pandemic on global AI in healthcare market?
• What is the anticipated futuristic impact of COVID-19 on AI adoption in the global healthcare market?
• What are the opportunities for AI healthcare startups in healthcare sector during the COVID-19 pandemic?
• Who are the leading players in global AI in healthcare market?
• What are the key business models prevalent in global AI in healthcare market?
• What type of products are anticipated to be launched during the forecast period 2021-2030?
• What are the key market drivers, restraints, and growth opportunities for the market?
• What was the market size for the various product types in the global AI in healthcare market in 2020? How are the product types anticipated to grow during the forecast period 2021-2030?
• What was the market size for various AI-enabled applications in healthcare in 2020? Which application is anticipated to grow with the highest CAGR during the forecast period 2021-2030?
• What was the market size of AI technologies, such as machine learning, deep learning, natural language processing, and computer vision in 2020? How are the technologies anticipated to grow during the forecast period, 2021-2030?
• Which region contributes the major share to the global AI in healthcare market? Which region holds significant growth potential during the forecast period 2021-2030?

Key USPs of the Report

Following are some of the key contents of the report:

• Funding Scenario

This section encompasses a description of the current funding landscape in the global AI in healthcare space for key players.

• Technology Readiness Index

This section is intended to aid the readers in identifying novel technology opportunities.

• Business Model Analysis

This section comprises information on the key business models deployed in the market by leading players.

• Impact of COVID-19

This section of the report encompasses the following:
o Impact on AI adoption
o Future impact (Short-, mid-, and long-term)
o Key developments during the COVID-19 pandemic

In addition, the report provides:

• A detailed analysis and growth forecast (2021-2030) for different market segments
• Recent developments and trends in the global market landscape
• Factors promoting and inhibiting the market growth
• Case studies to assess the delivery models and strategies adopted by some of the highly funded players in the market

Expert Quote

“At present, many companies refrain from venturing into this field as in many cases, companies pursue R&D without knowing whether their concept makes for a viable business model. Currently, most of the companies have their own unique model. However, four years down the line, the competition will be more intense, and the market would witness a repetition of existing services and offerings”.

Scope of the Global AI in Healthcare Market

The purpose of the study is to enable the reader to gain a holistic view of the global AI in healthcare market, by each of the segments mentioned above.

The report constitutes an in-depth analysis of the global AI in healthcare market, including a thorough analysis of the applications. The study also provides market and business-related information on various products, applications, technologies, and end users. The report considers integrated devices, software, and services related to AI in healthcare.

The post Global AI in Healthcare Market: Analysis and Forecast, 2021-2030 first appeared on CRI Report.

Market Segmentation

• Product Type – Consumables(Media, Rapid Detection Assays, Reagents and Supplements, Accessories), Equipment and Systems(Filtration Systems, Microbial Detection Systems, Incubators and Culture Systems, Air Monitoring Systems, Sterilization Systems, Others)
• By Application – Pharmaceutical Industry, Food and Beverage Industry, Cosmetic Industry, Water Industry, Biotechnology Industry, Other Industries
• By End User – Biotechnology and Pharmaceutical Companies, Commercial Quality Assurance, Food and Beverage Companies, Research Institutions, Regulatory and Environmental Agencies, Other Industrial End Users

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, France, U.K., Italy, Spain, and Rest-of-Europe
• Asia-Pacific – China, Japan, India, Australia, and Rest-of-Asia-Pacific (RoAPAC)
• Latin America – Brazil, Mexico, and Rest-of-the-Latin America
• Rest-of-the-World

Growth Drivers

• Growing research and development activity in different industry
• Technological advancements for commercial quality assurance
• Growing demand for safety in food and pharmaceutical industry triggers the market growth

Market Challenges

• Dearth of skilled professional in industrial microbiology laboratories
• High cost of industrial microbiology process

Market Opportunities

• Growing demand for innovative analytic techniques
• Technological advancement in real-time environment monitoring

Key Companies Profiled

3M Company, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Charles River Laboratories International, Inc., Danaher Corporation, Eppendorf AG, HiMedia Laboratories, Hy Laboratories Ltd, Merck KGaA, Novamed, QIAGEN N.V., Sartorius AG, Solenis, Sysmex Corporation, Thermo Fisher Scientific Inc.

Key Questions Answered in this Report:

• What is industrial microbiology?
• How did the industrial microbiology market evolve, and what is its scope in the future?
• What are the major market drivers, restraints, and opportunities in the global industrial microbiology market?
• What are the key developmental strategies that are being implemented by the key players to sustain this market?
• What is the patent landscape of this market? What will be the impact of patent expiry on this market?
• What is the impact of COVID-19 on this market?
• What are the guidelines implemented by different government bodies to regulate the approval of products to be used in industrial microbiology?
• How is industrial microbiology being utilized for the development of therapeutics?
• How will the investments by public and private companies and government organizations affect the global industrial microbiology market?
• What was the market size of the leading segments and sub-segments of the global industrial microbiology market in 2019?
• How will the industry evolve during the forecast period 2020-2030?
• What will be the growth rate of the industrial microbiology market during the forecast period?
• How will each of the segments of the global industrial microbiology market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2030?
• Which product segment and application segment are expected to register the highest CAGR for the global industrial microbiology market?
• What are the major benefits of the implementation of industrial microbiology strategies in different field of applications including pharmaceutical industry, food and beverage industry, cosmetic industry, water industry, biotechnology Industry and other industry?
• What is the market size of the industrial microbiology market in different countries of the world?
• Which geographical region is expected to contribute to the highest sales of industrial microbiology market?
• What are the regulatory and biosafety framework for the industrial microbiology market in different regions?
• What are the key strategies incorporated by the players of global industrial microbiology market to sustain the competition and retain their supremacy?

Market Overview

The capability of genetically engineered cells to make new products revolutionized the processes of industrial microbiology. Techniques like gene mounting and genetic engineering have helped the fermentation industry with enhanced productivity. The use of bioprocesses helped the industries to deliver fine-quality products. The application of industrial microbiology is currently expanding in areas such as therapeutics, diagnostics, environmental protection, mineral recovery, and agriculture, apart from its traditional application in the food and beverage industry.

The global industrial microbiology market was valued to be $5,604.2 million in 2019 and is expected to reach $13,181.2 million by 2030, witnessing a CAGR of 8.36% during the forecast period 2020-2030. The market growth can mainly be attributed to the growing research in the field of industrial microbiology, increasing awareness among researchers about new strains of microorganisms, rise in preference toward consumer products, increase in research and development as well as collaborations in pharmaceutical and biotechnology industries, and use of rapid sterility testing methods for pathogen detection.

The global industrial microbiology market has witnessed high growth in the last decade. The increase in demand for industrial microbiology products can largely be attributed to factors such as increase in the significance of industrial food and safety, growing awareness among researchers about new strains of microorganisms, increasing demand for pathogen testing in food products, growing research initiatives in different fields of industrial microbiology, increasing automation in products, and rising number of collaborations among companies.

Furthermore, the companies are investing huge amount toward innovations of industrial microbiology products. Key strategies followed by the companies include new product launches and mergers and acquisitions for geographical expansion and strengthening of product portfolios. For instance, in February 2019, bioMerieux SA acquired Invisible Sentinel, a U.S.-based company specialized in food and beverage molecular testing, to add the VERIFLOW platform to its industrial microbiology product portfolio. It is an innovative molecular biology solution for the detection of pathogens and spoilage organisms in food and beverages, wine and beer.
Within the research report, the market is segmented based on product type, application, end-user, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The global industrial microbiology market is currently dominated by Thermo Fisher Scientific, followed by bioMérieux SA. The market dominance of Thermo Fisher Scientific can be attributed to a large product portfolio for automated microbial detection systems. bioMérieux SA held the second largest market share in the industrial microbiology market, attributed to its significant contribution in the field. The company offers a wide range of products to be utilized for industrial procedures in the biopharmaceutical, food and beverages, and water industry. Merck KGaA holds the third largest share, owing to its diverse range of product offerings in consumables (including media, detection kits, and accessories) and detection systems. Other prominent players, namely, 3M, BD, Bio-Rad Laboratories, Inc., bioMérieux SA, Charles River Laboratories International, Inc., Pall/Danaher Corporation, Merck KGaA, and Eppendorf, collectively hold a large market share of the total global industrial microbiology market in 2019.

Based on region, North America is the leading contributor to the industrial microbiology market in terms of revenue. The fields such as commercial quality assurance and biotechnology & pharmaceutical companies are expected to progress at significant rates, and the substantial investments made in these fields are consequentially promoting the growth of the North America industrial microbiology market. However, the Asia-Pacific and Europe regions, constituting several emerging companies contributing to industrial microbiology, are expected to register the high CAGR during the forecast period of 2020-2030.

The post Global Industrial Microbiology Market: Focus on Products, Applications, End Users, Country Data (13 Countries), and Competitive Landscape – Analysis and Forecast, 2020-2030 first appeared on CRI Report.